MXCT vs NUE · rev $38.6M vs P/E 25, rev $7.08B
MaxCyte Inc (MXCT) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
MXCT currently screens at market cap $124.3M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the MXCT and NUE stock pages for the full models.
Not investment advice.